Drug Shortage Report for PMS-CYTARABINE
Report ID | 146890 |
Drug Identification Number | 02406772 |
Brand name | PMS-CYTARABINE |
Common or Proper name | CYTARABINE |
Company Name | PHARMASCIENCE INC |
Market Status | MARKETED |
Active Ingredient(s) | CYTARABINE |
Strength(s) | 100MG |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS INTRAVENOUS INTRATHECAL SUBCUTANEOUS INTRAVENOUS INTRATHECAL |
Packaging size | 2000mg/20mL |
ATC code | L01BC |
ATC description | ANTIMETABOLITES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2022-01-04 |
Actual start date | |
Estimated end date | 2022-02-25 |
Actual end date | 2022-02-15 |
Shortage status | Resolved |
Updated date | 2022-02-16 |
Company comments | Limited supply. Anticipated BO from January 4, 2022 to February 25, 2022 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v16 | 2022-02-16 | French | Compare |
v15 | 2022-02-16 | English | Compare |
v14 | 2022-01-05 | English | Compare |
v13 | 2021-12-01 | French | Compare |
v12 | 2021-12-01 | English | Compare |
v11 | 2021-11-23 | French | Compare |
v10 | 2021-11-23 | English | Compare |
v9 | 2021-11-08 | French | Compare |
v8 | 2021-11-08 | English | Compare |
v7 | 2021-11-05 | French | Compare |
v6 | 2021-11-05 | English | Compare |
v5 | 2021-11-05 | English | Compare |
v4 | 2021-10-28 | French | Compare |
v3 | 2021-10-28 | English | Compare |
v2 | 2021-10-07 | French | Compare |
v1 | 2021-10-07 | English | Compare |
Showing 1 to 16 of 16